Coagulative disorders in critically ill COVID-19 patients with acute distress respiratory syndrome: a critical review
In critically ill patients with acute respiratory distress syndrome (ARDS) coronavirus disease
2019 (COVID-19), a high incidence of thromboembolic and hemorrhagic events is reported …
2019 (COVID-19), a high incidence of thromboembolic and hemorrhagic events is reported …
COVID-19 Coagulopathy: Current knowledge and guidelines on anticoagulation
Abstract COVID-19-associated coagulopathy (CAC) is a feature of COVID-19 that can lead
to various thrombotic complications and death. In this review, we briefly highlight possible …
to various thrombotic complications and death. In this review, we briefly highlight possible …
COVID-19-induced coagulopathy: Experience, achievements, prospects
The presence of coagulopathy as part of the systemic inflammatory response syndrome is a
characteristic feature of severe coronavirus disease 2019 (COVID-19). Hematological …
characteristic feature of severe coronavirus disease 2019 (COVID-19). Hematological …
Coagulation dysfunction: a hallmark in COVID-19
Context.—The coronavirus disease 2019 (COVID-19) is a highly contagious respiratory
disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …
disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …
[HTML][HTML] A prospective study of specialized coagulation parameters in admitted COVID-19 patients and their correlation with acute respiratory distress syndrome and …
Background Acute respiratory distress syndrome (ARDS) is a frequent complication of
COVID-19 and is associated with a component of thrombo-inflammation and cytokine storm …
COVID-19 and is associated with a component of thrombo-inflammation and cytokine storm …
Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past
Abstract Coronavirus disease 2019 (COVID-19) or severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), a novel coronavirus strain disease, has recently emerged in …
coronavirus 2 (SARS-CoV-2), a novel coronavirus strain disease, has recently emerged in …
[HTML][HTML] COVID-19-associated coagulopathy
M Franchini, G Marano, M Cruciani, C Mengoli, I Pati… - Diagnosis, 2020 - degruyter.com
Abstract Coronavirus disease 2019 (COVID-19), a viral respiratory illness caused by the
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been recently …
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been recently …
Coagulopathy during COVID-19 infection: a brief review
RM Cunningham, KL Johnson Moore… - Clinical and Experimental …, 2023 - Springer
The COVID-19 pandemic caused by SARS-CoV-2 continues to spread rapidly due to its
virulence and ability to be transmitted by asymptomatic infected persons. If they are present …
virulence and ability to be transmitted by asymptomatic infected persons. If they are present …
The impact of SARS-CoV-2 infection on blood coagulation and fibrinolytic pathways: a review of prothrombotic changes caused by COVID-19
M Bahraini, A Dorgalaleh - Seminars in Thrombosis and …, 2022 - thieme-connect.com
The cardinal pathology of coronavirus disease 2019 (COVID-19) is a primary infection of
pulmonary tract cells by severe acute respiratory syndrome coronavirus 2, provoking a local …
pulmonary tract cells by severe acute respiratory syndrome coronavirus 2, provoking a local …
Coronavirus disease 2019–associated coagulopathy
Patients with the severe form of coronavirus disease 2019 (COVID-19) have been frequently
found to suffer from both arterial and venous thrombotic events due to the perpetuation of a …
found to suffer from both arterial and venous thrombotic events due to the perpetuation of a …